TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,428,163 | -7.1% | 147,340 | -12.0% | 0.07% | -9.5% |
Q4 2022 | $2,613,125 | +1401.8% | 167,508 | +1151.4% | 0.07% | +1133.3% |
Q3 2022 | $174,000 | -73.8% | 13,386 | -71.7% | 0.01% | -80.0% |
Q2 2022 | $664,000 | +45.3% | 47,273 | +41.0% | 0.03% | +7.1% |
Q4 2021 | $457,000 | +69.3% | 33,525 | +122.4% | 0.03% | +47.4% |
Q2 2020 | $270,000 | +21.6% | 15,076 | +34.1% | 0.02% | +46.2% |
Q4 2019 | $222,000 | +21.3% | 11,243 | +5.5% | 0.01% | -18.8% |
Q3 2019 | $183,000 | – | 10,654 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |